FDA to Convene Pharmacy Compounding Advisory Committee in July Gray Market Peptides: So Much Hype, So Little Data FDA Peptide Reclassification 2026: What Researchers Want Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law FDA Schedules July 2026 PCAC Review of BPC 157, TB 500, MOTs C, KPV, Semax, Epitalon, DSIP PeptideRundown This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides